PBM Reform

PUTTbulletin May 2025 Something is seriously wrong with military prescription drug pricing, and it's time we talked about it. In the coming weeks PUTT will launch what we hope to be a provocative campaign focused on some troubling - but largely unacknowledged - questions: why are our military families and taxpayers paying dramatically inflated prices for generic prescription drugs through Tricare's PBM, Express Scripts? And what are we doing about it? It’s a Problem We Can’t

May 30, 2025 The Honorable Joseph Lombardo  Governor of Nevada  101 N. Carson Street  Carson City, NV 89701 Dear Governor Lombardo, I am reaching out to you today on behalf of Nevada’s independent pharmacies and their patients to respectfully urge you to veto Assembly Bill 259, which would implement prescription drug price controls similar to those established under the Medicare Drug Price Negotiation provisions of the Inflation Reduction Act . Community pharmacists are deepl

Sen. Chuck Grassley, R-Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after it passes...

Let’s cut the nonsense: pharmacy benefit managers (PBMs) aren’t just shady middlemen—they’re operating a masterclass in anti-competitive...

PUTTbulletin April 2025 As you read this, the PUTT Board is in Washington D.C. taking part in NCPA’s annual Congressional Fly In. We’re excited to join our fellow members, NCPA friends and other partners in PBM reform for 2 days of face-to-face meetings with federal policy makers about the need for PBM reform NOW. On Monday, April 28, PUTT Board member Brandi Chane participated in the House Judiciary Antitrust Subcommittee Panel PBMs: The Drug Middlemen Who Increase Drug Pric

The worst marriage in the history of healthcare is the unholy union of PBMs (pharmacy benefit managers) and formulary design. This carefree couple has fostered the creation of inconceivably high priced brand drugs in the U.S. market for decades, and we need an immediate annulment. Plan formularies are more influenced by quid pro quo payments between PBMs and drugmakers than clinical guidelines. Thanks to a safe harbor exemption from the Anti-Kickback Statute, PBMs can legall

The state officials claim that ownership limits competition Consumer Affairs Reporter: Mark Huffman Key takeaways State attorneys general...

Talking Points & Analysis of President Donald J. Trump Executive Order: LOWERING  DRUG PRICES BY ONCE AGAIN PUTTING AMERICANS FIRST ...

Arkansas Advocate Reporter: Tess Vrbin A House panel Wednesday approved a bill aimed at preventing pharmacy benefit managers (PBMs) from...

Whenever lawmakers begin discussing Pharmacy Benefit Manager (PBM) reform, a familiar pattern emerges: new advocacy groups, often with...

The Natchez Democrat Reporter: Jan Griffey A Natchez pharmacist is applauding legislation being considered by the Mississippi House and...

KRCR ABC News7 Reporter: AUSTIN DENEAN | The National News Desk The House is renewing a push to take on pharmacy benefit managers that...

Pharmacy benefit managers (PBMs) and their lobbyists have mastered the art of spin. They claim to lower drug prices, increase patient...

Modern Healthcare Reporter: Michael McAuliff Lawmakers who came within days of passing new restrictions on pharmacy benefit managers are...

KAKE News Reporter: Lily O'Brien When dozens of independent Kansas pharmacies close their doors Tuesday night, they won't open back up...

FOR IMMEDIATE RELEASE January 16, 2025 LITTLE ROCK, AR – In a bold move to enhance patient care and support local pharmacies, lawmakers in Arkansas have introduced a new bill aimed at banning pharmacies owned by the largest, vertically integrated pharmacy benefit managers (PBMs) from operating in the state. HB1150 is designed to improve patient access to medications, and ensure the sustainability of the state’s independent pharmacies, many operating in small or rural communit

KFF Health News Reporter: Arthur Allen Ann Lewandowski knows all about pharmacy benefit managers, or PBMs, the companies that shape the...

Ohio Capital Journal reporter: Marty Schladen Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus Monday, one of the country’s top antitrust watchdogs said her agency is taking a hard look at the businesses and their practices. Doha Mekki, the No. 2 official in the U.S. Justice Department’s Antitrust Division, said her agency is investigating whether it should take action in the health care space generall

Weatherford Democrat Reporter: Glenn Evans gevans@weatherforddemocrat.com A Weatherford pharmacist joined members of Congress and her peers from six states in Washington on Friday to raise support for a bill to rein in the pricing power of Pharmacy Benefit Managers. “Our country is facing an epidemic of pharmacy closures,” Brandi Chane, owner of Davis City Pharmacy on the courthouse square, said at a press conference below the Capitol dome. She and the others were there to ra

CNN Reporter: Tami Luhby , CNN The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit...